BUZZ-U.S. STOCKS ON THE MOVE-Horizon Pharma, Catamaran, Teva, Alibaba
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures rose on Monday, pointing to a second straight daily gain as a trio of M&A deals lifted sentiment after a recent bout of weakness. Dow Jones industrial average e-mini futures were up 0.62 percent at 17,735, S&P 500 futures were up 0.50 percent at 2,062.75 and Nasdaq 100 futures were up 0.63 percent at 4,353.
** CELLULAR DYNAMICS INTERNATIONAL INC, Friday close $7.94, +114.11 pct premarket
Japan's Fujifilm Holdings Corp said on Monday it has agreed to acquire U.S. biotechnology firm Cellular Dynamics International Inc (CDI) for $307 million.
** HORIZON PHARMA PLC, Friday close $21.81, +12.33 pct premarket
** HYPERION THERAPEUTICS INC, Friday close $42.74, +6.64 pct premarket
Ireland's Horizon said it would buy the U.S. drugmaker for about $1.1 billion to add to its line-up of drugs that treat rare diseases. Horizon will pay $46 per share, a premium of 7.6 percent to Hyperion's Friday closing price.
** UNITEDHEALTH GROUP, Friday close $118.01, +3.80 pct premarket Continued...